Tedopi
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Tedopi, covering 2025-12-04 to 2026-02-06. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy of Tedopi Plus Docetaxel or Tedopi Plus Nivolumab as Second-line Therapy in Metastatic Non-small-cell Lung Cancer Progressing After First-line Chemo-immunotherapy (Combi-TED) [Phase 2]